Emerging Therapeutics for Respiratory Dysfunction
Featured Topic — Monday, April 8, 2019 — 3:30 PM - 5:00 PM — Convention Center, Room W312B
Respiration Section — Chair: Darin Falk — Co-Chair: Leonardo Ferreira
Cosponsored by AJP - Lung Cellular and Molecular Physiology
The session will begin with the keynote speaker, Dr. Barry Byrne, discussing his efforts to cure neuromuscular diseases using gene therapy in both his basic science and clinical research programs. Dr. Byrne is a physician-scientist who specializes in rare genetic conditions such as Pompe disease and Duchene Muscular Dystrophy. As most patients affected by these conditions eventually require full-time mechanical ventilation, respiratory outcomes are particularly important when considering the efficacy of new treatment strategies, and will be highlighted during the talk.
The remaining speakers will be chosen on abstract-based submissions. We encourage abstract submissions across a range of emerging therapies including spinal cord stimulation, pharmacology, intermittent hypoxia, etc. The goal of the session is to highlight a variety of emerging therapeutic strategies to restore breathing following injury or disease.
- Gene Therapy for the Treatment of Neuromuscular Disease
Barry Byrne — Center for Respiratory Research and Rehabilitation College of Public Health and Health Professions, University of Florida
Mai K. ElMallah — Pediatrics, Duke University
Erica Arden Dale — Department of Neuroscience, College of Medicine, University of Florida
Stephane Vinit — U1179 INSERM, Université de Versailles Saint Quentin en Yvelines
Emily J. Fox — Physical Therapy, University of Florida